| Reference |
|---|
Chaib S, L xf3 pez Dom xed nguez J, Lalinde Guti xe9 rrez M, Prats N, Marin I, Boix O, et al. The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nat Cancer. 2024;: pubmed publisher
|
Zhang J, Ye Z, Br xe4 utigam L, Chakraborty P, Luo Z, Culpepper J, et al. A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progression. J Biol Chem. 2023;299:104920 pubmed publisher
|
Chang Y, Jin G, Luo W, Luo Q, Jung J, Hummel S, et al. Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioact Mater. 2023;27:168-180 pubmed publisher
|
Swan S, Mehta N, Ilich E, Shen S, Wilkinson D, Anderson A, et al. IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma. Front Immunol. 2023;14:1085547 pubmed publisher
|
Sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S, et al. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization. J Transl Med. 2023;21:132 pubmed publisher
|
Juras P, Racioppi L, Mukherjee D, Artham S, Gao X, Akullian D Agostino L, et al. Increased CaMKK2 Expression Is an Adaptive Response That Maintains the Fitness of Tumor-Infiltrating Natural Killer Cells. Cancer Immunol Res. 2023;11:109-122 pubmed publisher
|
Dai T, Rosario S, Katsuta E, Sawant Dessai A, Paterson E, Novickis A, et al. Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Cell Rep. 2022;41:111756 pubmed publisher
|
Russell S, Lim F, Peters P, Wardell S, Whitaker R, Chang C, et al. Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer. Cancers (Basel). 2022;14: pubmed publisher
|
Nemudraia A, Nemudryi A, Buyukyoruk M, Scherffius A, Zahl T, Wiegand T, et al. Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic. Res Sq. 2022;: pubmed publisher
|
Ren Q, Khoo W, Corr A, Phan T, Croucher P, Stewart S. Gene expression predicts dormant metastatic breast cancer cell phenotype. Breast Cancer Res. 2022;24:10 pubmed publisher
|
Polyanskaya S, Moreno R, Lu B, Feng R, Yao Y, Irani S, et al. SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia. Cell Rep. 2022;38:110233 pubmed publisher
|
Wei Y, Huang Y, Skopelitis D, Iyer S, Costa A, Yang Z, et al. SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia. Cancer Discov. 2021;: pubmed publisher
|
Feng W, Cao Z, Lim P, Zhao H, Luo H, Mao N, et al. Rapid interrogation of cancer cell of origin through CRISPR editing. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
|
Yang Z, Wu X, Wei Y, Polyanskaya S, Iyer S, Jung M, et al. Transcriptional silencing of ALDH2 confers a dependency on Fanconi anemia proteins in acute myeloid leukemia. Cancer Discov. 2021;: pubmed publisher
|
Kretschmer M, Kadlubowska P, Hoffmann D, Schwalbe B, Auerswald H, Schreiber M. Zikavirus prME Envelope Pseudotyped Human Immunodeficiency Virus Type-1 as a Novel Tool for Glioblastoma-Directed Virotherapy. Cancers (Basel). 2020;12: pubmed publisher
|
Lu B, Klingbeil O, Tarumoto Y, Somerville T, Huang Y, Wei Y, et al. A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence. Cancer Cell. 2018;34:970-981.e8 pubmed publisher
|
Somerville T, Xu Y, Miyabayashi K, Tiriac H, Cleary C, Maia Silva D, et al. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Cell Rep. 2018;25:1741-1755.e7 pubmed publisher
|
Xu Y, Milazzo J, Somerville T, Tarumoto Y, Huang Y, Ostrander E, et al. A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell. 2018;33:13-28.e8 pubmed publisher
|